M.-C. Fournié-Zaluski

Author

Also Known As

M C Fournie-Zaluski, M C Fournié-Zaluski, M ‐C Fournié‐Zaluski, M. C. Fournie-Zaluski, M. C. Fournié-Zaluski, M.-C Fournie-Zaluski, M.-C. Fournie-Zaluski, M.-C. Fournié-Zaluski, M.C Fournié-Zaluski, M.C. FOURNIE-ZALUSKI

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre National de la Recherche Scientifique Laboratoire de Chimie Organique Université Paris Cité Département de Pharmacochimie Moléculaire

About

M.-C. Fournié-Zaluski is an author at Inserm specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.6K
2	Health Sciences	10	10	321
3	Natural Sciences	10	11	447
4	Social Sciences	2	2	85
5	Engineering	1	1	280

M.-C. Fournié-Zaluski

Publications

Citations

H-Index

Page 1

	Year	Citations
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Sylvie Zini, M.-C. Fournié-Zaluski, Eric N. Chauvel, Proceedings of the National Academy of Sciences HypertensionBrain Angiotensin IiBlood PressureAngiotensin IiiMolecular Pharmacology	1996	319
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Hugues de Rocquigny, Caroline Gabus, Annelet Vincent, Proceedings of the National Academy of Sciences Viral RnaViral Rna DimerizationViral ReplicationEngineeringViral Rna Binding	1992	280
Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR Nelly Morellet, Hugues de Rocquigny, Yves Mély, Journal of Molecular Biology Virus StructureBiochemistryProtein FoldingNatural SciencesOligonucleotide	1994	142
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: A potential treatment of salt-dependent hypertension M.-C. Fournié-Zaluski, Céline Fassot, Bruno Valentin, Proceedings of the National Academy of Sciences HypertensionPharmacotherapyBlood PressureNeurologySalt-dependent Hypertension	2004	132
Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site. Alain Devault, Christiane Nault, M Zollinger, Journal of Biological Chemistry Protein SecretionMolecular BiologyEnzymatic ModificationRabbit Kidney CdnaBiosynthesis	1988	120
Potent antinociceptive effects of Kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats V. Kayser, M.-C. Fournié-Zaluski, G. Guilbaud, Brain Research InflammationAnti-inflammatoryMedicineNeuropathic PainNeuropharmacology	1989	99
First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129 Florence Noble, Ghazal Banisadr, Fanny Jardinaud, Neuroscience	2001	65
Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord Anthony H. Dickenson, Ann F. Sullivan, M.-C. Fournié-Zaluski, Brain Research Pain MedicineNeuropathic PainMolecular PainNociceptive NeuronesEndogenous Enkephalins	1987	60
Differences in physical dependence induced by selective μ or δ opioid agonists and by endogenous enkephalins protected by peptidase inhibitors Rafaël Maldonado, Jean Féger, M.-C. Fournié-Zaluski, Brain Research Opioid EpidemicMolecular PharmacologyAddictionDrug DiscoveryPhysiology	1990	59
Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation Rafaël Maldonado, Olga Valverde, Serge Turcaud, Pain Pain MedicineImmunologyNeuropathic PainMolecular PainPharmacotherapy	1994	53

Page 1